Palvella Therapeutics PVLA
NASDAQ PVLA
$137.93 -1.07 (-0.77%)
At close: Sep 30, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Receivables - Other (2022 - 2024)

Updated

Palvella Therapeutics (PVLA) recorded Receivables - Other of $506,000 in Q3 2024, down 83.4% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Receivables - Other (2022 - 2024) Analysis & Trends

At the end of FY2023, Palvella Therapeutics reported Receivables - Other of $3.14 million, down 34.2% from FY2022.

  • Across earlier years, Receivables - Other came in at $4.77 million in FY2022.
  • Per Business Quant, the preceding three quarters came in at $3.05 million (Q2 2024), $3.07 million (Q1 2024) and $3.14 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Palvella Therapeutics 2.00 Bn 1.75 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 506,000.00
Jun 30, 2024 3.05 Mn
Mar 31, 2024 3.07 Mn
Dec 31, 2023 3.14 Mn
Dec 31, 2022 4.77 Mn
API Access

Palvella Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=PVLA&period=max&api_key=YOUR_API_KEY